Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

SOPHiA GENETICS (SOPH) EPS (Basic) (2020 - 2025)

Historic EPS (Basic) for SOPHiA GENETICS (SOPH) over the last 6 years, with Q2 2025 value amounting to $37989.8.

  • SOPHiA GENETICS's EPS (Basic) rose 1002.12% to $37989.8 in Q2 2025 from the same period last year, while for Jun 2025 it was $37989.8, marking a year-over-year increase of 1002.12%. This contributed to the annual value of -$55394.7 for FY2021, which is 3095.68% down from last year.
  • According to the latest figures from Q2 2025, SOPHiA GENETICS's EPS (Basic) is $37989.8, which was up 1002.12% from $34529.5 recorded in Q2 2024.
  • SOPHiA GENETICS's EPS (Basic)'s 5-year high stood at $37989.8 during Q2 2025, with a 5-year trough of -$492500.0 in Q1 2023.
  • Its 5-year average for EPS (Basic) is -$103061.9, with a median of $7785.8 in 2021.
  • In the last 5 years, SOPHiA GENETICS's EPS (Basic) crashed by 24259.83% in 2021 and then surged by 21012.0% in 2022.
  • Over the past 5 years, SOPHiA GENETICS's EPS (Basic) (Quarter) stood at -$16070.7 in 2021, then surged by 296.89% to $31642.3 in 2022, then grew by 5.65% to $33431.2 in 2023, then increased by 3.29% to $34529.5 in 2024, then grew by 10.02% to $37989.8 in 2025.
  • Its EPS (Basic) stands at $37989.8 for Q2 2025, versus $34529.5 for Q2 2024 and $33431.2 for Q2 2023.